Long-Term Colchicine for the Prevention of Vascular Recurrent Events in Patients After a Noncardioembolic Stroke
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial
Lancet 2024 Jun 07;[EPub Ahead of Print], P Kelly, R Lemmens, C Weimar, C Walsh, F Purroy, M Barber, R Collins, S Cronin, A Czlonkowska, P Desfontaines, A De Pauw, NR Evans, U Fischer, C Fonseca, J Forbes, MD Hill, D Jatuzis, J Kõrv, P Kraft, C Kruuse, C Lynch, D McCabe, R Mikulik, S Murphy, P Nederkoorn, M O'Donnell, P Sandercock, B Schroeder, G Shim, K Tobin, DJ Williams, C PriceFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.